The antitrypanosomal drug melarsoprol competitively inhibits thiamin uptake in mouse neuroblastoma cells
- 1 May 2006
- journal article
- Published by Springer Nature in Cell Biology and Toxicology
- Vol. 22 (3) , 183-187
- https://doi.org/10.1007/s10565-006-0034-z
Abstract
Melarsoprol is the main drug used for the treatment of late-stage sleeping sickness, although it causes severe side-effects such as encephalopathy and polyneuropathy leading to death in some patients. Recent data suggest that melarsoprol and its active metabolite melarsenoxide interfere with thiamin transport and metabolism in E. coli and yeast, but there are no data concerning their possible effects on thiamin metabolism in mammalian cells. We tested both drugs on thiamin transport in cultured mouse neuroblastoma cells using 14C-labeled thiamin. Melarsoprol, competitively inhibits high-affinity thiamin transport in mouse neuroblastoma cells with a K i of 44 μmol/L. However, the active compound melarsenoxide has no inhibitory effect. This suggests that the side effects of melarsoprol treatment are unlikely to be due to inhibition of thiamin transport by melarsenoxide, its main metabolite in the brain.Keywords
This publication has 16 references indexed in Scilit:
- Drug transport and drug resistance in African trypanosomesDrug Resistance Updates, 2003
- Current chemotherapy of human African trypanosomiasisZeitschrift Fur Parasitenkunde-Parasitology Research, 2003
- Clinical description of encephalopathic syndromes and risk factors for their occurrence and outcome during melarsoprol treatment of human African trypanosomiasisTropical Medicine & International Health, 2001
- Identification and Characterization of the Human and Mouse SLC19A3 Gene: A Novel Member of the Reduced Folate Family of Micronutrient Transporter GenesMolecular Genetics and Metabolism, 2000
- Investigations of the metabolites of the trypanocidal drug melarsoprolClinical Pharmacology & Therapeutics, 2000
- Cloning of the Human Thiamine Transporter, a Member of the Folate Transporter FamilyJournal of Biological Chemistry, 1999
- A Nucleoside Transporter from Trypanosoma brucei Involved in Drug ResistanceScience, 1999
- Mutations in a new gene encoding a thiamine transporter cause thiamine-responsive megaloblastic anaemia syndromeNature Genetics, 1999
- Arsenical-resistant trypanosomes lack an unusual adenosine transporterNature, 1993
- Mel B in the Treatment of Human TrypanosomiasisThe American Journal of Tropical Medicine, 1949